AusperBio Revenue and Competitors
Employee Data
- AusperBio has 6 Employees.
- AusperBio grew their employee count by 100% last year.
AusperBio's People
| Name | Title | Email/Phone |
|---|
AusperBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is AusperBio?
AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B. The company has developed a proprietary Med-OligoTM ASO platform with novel insights into ASO design and capabilities to substantially enhance the current ASO therapeutics. Combining with efficient targeted delivery conjugation technologies, the modular Med-OligosTM Platform empowers ASO therapeutics to treat broad viral infections, metabolic conditions, genetic disorders, and immune diseases.
keywords:N/A
N/A
Total Funding
6
Number of Employees
N/A
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Mateo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A |
#2 | N/A | 6 | 0% | N/A |
#3 | $0.1M | 6 | 0% | $9.8M |
#4 | $0.9M | 6 | -40% | N/A |
#5 | $0.9M | 6 | 0% | N/A |